Immune and cellular damage biomarkers to predict COVID-19 mortality in hospitalized patients

MLA

Carlo Lombardi, et al. “Immune and Cellular Damage Biomarkers to Predict COVID-19 Mortality in Hospitalized Patients.” Current Research in Immunology, vol. 2, no. 155–162, Jan. 2021, pp. 155–62. EBSCOhost, https://doi.org/10.1016/j.crimmu.2021.09.001.

APA

Carlo Lombardi, Elena Roca, Barbara Bigni, Bruno Bertozzi, Camillo Ferrandina, Alberto Franzin, Oscar Vivaldi, Marcello Cottini, Andrea D’Alessio, Paolo Del Poggio, Gian Marco Conte, & Alvise Berti. (2021). Immune and cellular damage biomarkers to predict COVID-19 mortality in hospitalized patients. Current Research in Immunology, 2(155–162), 155–162. https://doi.org/10.1016/j.crimmu.2021.09.001

Chicago

Carlo Lombardi, Elena Roca, Barbara Bigni, Bruno Bertozzi, Camillo Ferrandina, Alberto Franzin, Oscar Vivaldi, et al. 2021. “Immune and Cellular Damage Biomarkers to Predict COVID-19 Mortality in Hospitalized Patients.” Current Research in Immunology 2 (155–162): 155–62. doi:10.1016/j.crimmu.2021.09.001.